A further contribution to the G6PD inhibition may be related to the increased glucagon level, which is always present to some extent in diabetes, given that it is known that the injection of glucagon into experimental animals reduces G6PD activity [71]. The gene discussed is GCG; the disease is diabetes mellitus.